Pharmaceutical Serialization Further Expands Digital Scope
Pharmaceutical serialization mandates across an expanding list of jurisdictions increasingly require unit-level variable-data printing previously achievable only through digital presses, since regulators increasingly treat counterfeit drug infiltration as a risk that unit-level serialization can meaningfully reduce. This shift is creating substantial new demand beyond the category's traditional craft beverage base, giving digital press manufacturers a genuine growth avenue tied to regulatory expansion rather than pure short-run volume growth. Manufacturers with established variable-data software integration capability are capturing disproportionate share of this expanding demand across newly regulated markets worldwide. That pattern shows few signs of slowing down across major accounts today.
Market Impact: Sustains over 31% of unit volume








